RTTNews | Jul 20, 2020 11:16AM EDT

11:15 Monday, July 20, 2020 (RTTNews.com) - Shares of Aclaris Therapeutics, Inc. (ACRS) are currently gaining nearly 40% on Monday morning despite no stock-specific news. Pharma companies are performing better on Monday as investors are more interested in the industry on the back of positive reports of COVID-19 vaccine.

ACRS is currently trading at $3.08, up $0.87 or 39.37%, on the Nasdaq.

Aclaris Therapeutics is a biopharmaceutical company focused on developing drug candidates for immuno-inflammatory diseases in the US. It operates in two segments, Therapeutics and Contract Research.

Meanwhile, a coronavirus vaccine the University of Oxford is developing with AstraZeneca demonstrated promising results in early human testing.

Read the original article on RTTNews ( https://www.rttnews.com/3112428/stock-alert-aclaris-therapeutics-up-40.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved